Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001159036-26-000045
Filing Date
2026-03-23
Accepted
2026-03-23 18:35:07
Documents
4
Period of Report
2026-03-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1774305304.html 3  
1 FORM 3 wk-form3_1774305304.xml 3 1840
2 EX-24 ramsay-edgarnextpoafinal.htm EX-24 6775
3 GRAPHIC ramsay-edgarnextpoafinal001.jpg GRAPHIC 240419
4 GRAPHIC ramsay-edgarnextpoafinal002.jpg GRAPHIC 218795
  Complete submission text file 0001159036-26-000045.txt   643002
Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Issuer) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address HALOZYME THERAPEUTICS, INC. 11588 SORRENTO VALLEY ROAD, #17 SAN DIEGO CA 92121
Business Address
RAMSAY DAVID A (Reporting) CIK: 0001283292 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32335 | Film No.: 26783731